Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

716
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
716
Drug Discovery: Overview01:26

Drug Discovery: Overview

7.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.9K
Molecular Models02:00

Molecular Models

38.3K
Physical models representing molecular architectures of chemical compounds play essential roles in understanding chemistry. The use of molecular models makes it easier to visualize the structures and shapes of atoms and molecules.
38.3K
Drug-Receptor Bonds01:25

Drug-Receptor Bonds

2.8K
Drug-receptor bonds are formed through various chemical forces when drugs interact with target cells. Covalent bonds, strong and irreversible, are exemplified by DNA-alkylating anticancer agents that inhibit cell division. However, such irreversible drug binding lacks selectivity and can modify the DNA of the surrounding healthy cells. Covalent binding often contributes to tissue toxicity, as seen with chloroform and paracetamol metabolites binding to the liver, causing hepatotoxicity.
In...
2.8K
Ligand Binding Sites02:40

Ligand Binding Sites

12.8K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
12.8K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Synthesis of 3-desoxycollinoketone B and its ability to reduce Alzheimer-associated misfolded proteins.

Nature communications·2026
Same author

Riemannian denoising model for molecular structure optimization with chemical accuracy.

Nature computational science·2026
Same author

Engineering Excited States of Pt-Based Deep-Blue Phosphors to Enhance OLED Stability.

ACS omega·2025
Same author

MetalloGen: Automated 3D Conformer Generation for Diverse Coordination Complexes.

Journal of chemical information and modeling·2025
Same author

BInD: Bond and Interaction-Generating Diffusion Model for Multi-Objective Structure-Based Drug Design.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2025
Same author

Enhanced Quantum Yield and Long-Term Stability of Eco-Friendly Water-Dispersed InP/ZnSe/ZnS Quantum Dots via Photochemical Surface Passivation.

The journal of physical chemistry letters·2025

相关实验视频

Updated: Jun 29, 2025

Generation of High-Throughput Three-Dimensional Tumor Spheroids for Drug Screening
05:54

Generation of High-Throughput Three-Dimensional Tumor Spheroids for Drug Screening

Published on: September 5, 2018

8.6K

3D分子生成框架用于交互导向药物设计.

Wonho Zhung1, Hyeongwoo Kim1, Woo Youn Kim2,3,4

  • 1Department of Chemistry, KAIST, 291 Daehak-ro, Yuseong-gu, Daejeon, 34141, Republic of Korea.

Nature communications
|March 28, 2024
PubMed
概括
此摘要是机器生成的。

这项研究引入了用于药物设计的相互作用意识的3D分子生成框架. 该模型通过学习蛋白质-连接体相互作用模式来增强概括性和创新性,改善针对新型标的药物发现.

更多相关视频

Curation of Computational Chemical Libraries Demonstrated with Alpha-Amino Acids
08:21

Curation of Computational Chemical Libraries Demonstrated with Alpha-Amino Acids

Published on: April 13, 2022

2.6K
Interactive Molecular Model Assembly with 3D Printing
06:15

Interactive Molecular Model Assembly with 3D Printing

Published on: August 13, 2020

10.0K

相关实验视频

Last Updated: Jun 29, 2025

Generation of High-Throughput Three-Dimensional Tumor Spheroids for Drug Screening
05:54

Generation of High-Throughput Three-Dimensional Tumor Spheroids for Drug Screening

Published on: September 5, 2018

8.6K
Curation of Computational Chemical Libraries Demonstrated with Alpha-Amino Acids
08:21

Curation of Computational Chemical Libraries Demonstrated with Alpha-Amino Acids

Published on: April 13, 2022

2.6K
Interactive Molecular Model Assembly with 3D Printing
06:15

Interactive Molecular Model Assembly with 3D Printing

Published on: August 13, 2020

10.0K

科学领域:

  • 计算化学是一种计算化学.
  • 药物发现 药物发现
  • 医学中的人工智能

背景情况:

  • 深度生成模型显示了加速药物设计的前景.
  • 现有的模型在概括和数据限制方面扎,阻碍了创新的药物设计,并导致与未见的标蛋白产生不利的相互作用.

研究的目的:

  • 提出一种以相互作用为基础的3D分子生成框架,用于在目标结合口袋内以相互作用为指导的药物设计.
  • 提高药物设计的概括性和创新性,特别是在有限的实验数据下.

主要方法:

  • 开发了一个互动意识的3D分子生成框架.
  • 作为先前的知识,利用了蛋白质 - 配体相互作用的普遍模式.
  • 对未见的目标生成的配体进行模型性能评估,评估结合姿势的稳定性,亲和力,几何图案,多样性和新性.

主要成果:

  • 拟议的框架即使在有限的实验数据中也显示出高度的概括性.
  • 生成的配体对未见的标蛋白具有有利的相互作用和理想的特性.
  • 该模型成功设计了潜在的突变选择性抑制剂,展示了其在基于结构的药物设计中的适用性.

结论:

  • 交互意识的生成框架有效地解决了药物设计中现有模型的局限性.
  • 这种方法可以实现以相互作用为指导的药物设计,改善创新和通用性.
  • 这种方法在推进基于结构的药物设计和加速新疗法发现方面具有重大潜力.